ஸ்டீவன் கெட்சம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஸ்டீவன் கெட்சம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஸ்டீவன் கெட்சம் Today - Breaking & Trending Today

Why Amarin Trounced the Market on Tuesday

Author Bio
Eric has been writing about stocks and finance since the mid-1990s, when he lived in Prague, Czech Republic. Over the course of a varied career, he has also been a radio newscaster, an investment banker, and a bass player in a selection of rock and roll bands. A native New Yorker, he currently lives in Los Angeles.
What happened
Amarin (NASDAQ:AMRN) rose to end Tuesday nearly 5.1% higher after the company provided details from clinical studies of the components of its one commercialized drug.
So what
In a presentation at the American College of Cardiology s Annual Scientific Session, Amarin presented findings from a study of a key ingredient of that drug, cardiovascular treatment Vascepa (marketed as Vazkepa in the EU). ....

Steven Ketchum , American College Of Cardiology Annual Scientific Session , American College , Annual Scientific Session , Chief Scientific Officer Steven Ketchum , ஸ்டீவன் கெட்சம் , அமெரிக்கன் கல்லூரி ஆஃப் இருதயவியல் ஆண்டு அறிவியல் அமர்வு , அமெரிக்கன் கல்லூரி , ஆண்டு அறிவியல் அமர்வு ,

Amarin Corp. (AMRN) Highlights Multiple Scientific Findings for VASCEPA and Its Unique Active Ingredient at ACC

Amarin Corp. (AMRN) Highlights Multiple Scientific Findings for VASCEPA and Its Unique Active Ingredient at ACC
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , San Francisco , R Preston Mason , Suvasini Lakshmanan , Craig Granowitz , Steven Ketchum , Xiaowen Wang , Andrewp Ambrosy , Kaiser Permanente , American College Of Cardiology , Vascular Center , Harvard Medical School , Lundquist Institute At , Kaiser Permanente San Francisco Medical Center , Amarin Corporation , American College , Annual Scientific Session , Clinical Data , Hospital Heart , Lundquist Institute , Coronary Computed Tomography Angiography , Fractional Flow Reserve Computed Tomography , Action Insights , Kaiser Permanente Northern California , Audio Webcast Informationamarin , While Amarin ,

REDUCE-IT® Heart Failure Analyses by VASCEPA® (Icosapent Ethyl)-Driven Serum Eicosapentaenoic Acid (EPA) Levels Suggest Potential Benefit in New Heart Failure in Studied At-Risk Patients as Presented at the American College of Cardiology's 70th Annual Scientific Session

Share:
Post hoc analyses by estimated on-treatment serum EPA levels in the VASCEPA group suggest potentially reduced incidence of new heart failure and new heart failure requiring hospitalization with higher achieved serum EPA levels
Amarin to Webcast Discussion of Data Presented at ACC.21 Monday, May 17, 2021 at 4:30 p.m., Eastern Time
DUBLIN, Ireland and BRIDGEWATER, N.J., May 15, 2021 (GLOBE NEWSWIRE) Amarin Corporation plc (NASDAQ:AMRN) today announced the presentation of REDUCE-IT
® HEART FAILURE (HF) at ACC.21, the American College of Cardiology s 70th Annual Scientific Session, being held virtually from May 15 – 17, 2021. These new analyses supported by Amarin were presented on behalf of all authors by Deepak L. Bhatt, M.D., M.P.H., Brigham and Women s Hospital, Harvard Medical School, Boston, MA. ....

United States , New Jersey , United Arab Emirates , Clin Cardiol , Coll Cardiol , Craig Granowitz , Steven Ketchum , Deepakl Bhatt , American Heart Association , American College Of Cardiology , Drug Administration , Vascular Center , Harvard Medical School , Professor Of Medicine At Harvard Medical School , Exchange Commission , Amarin Corporation , Journal Of The American College Cardiology , European Union , Amarin Pharmaceuticals Ireland , A Report From The American Heart Association , Webcast Discussion , Data Presented , American College , Annual Scientific Session , Executive Director , Interventional Cardiovascular Programs ,

Why Amarin Stock Was a Winner Today | The Motley Fool

Why Amarin Stock Was a Winner Today | The Motley Fool
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.

Atlantic Ocean , Steven Ketchum , European Union , European Commission , Drug Administration , Hikma Pharmaceuticals , அட்லாண்டிக் கடல் , ஸ்டீவன் கெட்சம் , ஐரோப்பிய தொழிற்சங்கம் , ஐரோப்பிய தரகு , ஹிக்மா மருந்துகள் ,

VASCEPA® (Icosapent Ethyl) Found in Prespecified and Post Hoc Analyses to Significantly Reduce ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
VASCEPA® (Icosapent Ethyl) Found in Prespecified and Post Hoc Analyses to Significantly Reduce .
Amarin Corporation plcMarch 17, 2021 GMT
28% and 32% significant reductions in first and total strokes, respectively, demonstrated with VASCEPA compared to placebo, as well as reductions in first and total ischemic strokes each by 36%, without increasing hemorrhagic stroke, in statin-treated patients with elevated cardiovascular risk
Consistent reductions in overall stroke and in ischemic stroke observed across multiple subgroups
Administration of pure icosapent ethyl, VASCEPA, represents a novel clinical approach to stroke reduction
REDUCE-IT® STROKE abstract receives prestigious Paul Dudley White International Scholar Award to recognize the authors with the highest ranked abstract from the United States at the International Stroke Conference 2021 ....

United States , New Jersey , United Arab Emirates , Clin Cardiol , Coll Cardiol , Alina Kolomeyer , Steven Ketchum , Deepakl Bhatt , Paul Dudley White , American Heart Association , Harvard Medical School , Professor Of Medicine At Harvard Medical School , Exchange Commission , Paul Dudley White International Scholar Award , International Stroke Conference , Amarin Corporation , Journal Of The American College Cardiology , European Union , European Medicines Agency , Committee For Medicinal Products Human Use , A Report From The American Heart Association , Executive Director , Interventional Cardiovascular Programs , Paul Dudley White Award , New England Journal , American College ,